Young Adults' Fecundity Knowledge and Fertility Intentions and Reproductive Behavior
NCT ID: NCT06631950
Last Updated: 2025-04-02
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
NA
10000 participants
INTERVENTIONAL
2024-11-26
2045-10-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Study of Time to Pregnancy in Normal Fertility
NCT00161395
Couples Fertility and Pregnancy Awareness
NCT02813993
Enhancing Male Participation in Interventions to Prevent Unintended Pregnancy
NCT03514914
Testing the Impact of Two Posters on Contraceptive Knowledge, Contraceptive Preferences, and Perceived Pregnancy Risk
NCT03372369
Early Evaluation of the MAMAACT Trial
NCT04261400
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
The Danish National Birth Cohort (DNBC) is an ongoing nationwide cohort of women and their children with more than 20 years of follow-up data (Olsen et al., 2001). The cohort contains 92,000 women recruited 1996 to 2002, who experienced 100,000 pregnancies in total. It has a rich set of background variables including child's development and health up to 18 years, as well as self-reported measures from age 18 onwards. The oldest offspring in the DNBC will be 29 years old at the time of treatment.
The Norwegian Mother, Father and Child Cohort Study (MoBa) is built around 110,000 pregnancies recruited between 1999 and 2008 (Magnus et al., 2016). Children have reported on their own health and exposures from the age of 13, and health and socioeconomic status were reported by the parents before this age. The RCT study will be conducted on a subsample of the MoBa children who are at least 18 years old as of 2024. The oldest offspring in the MoBa will be 25 years old at the time of treatment.
Data collection for the RCT will take place between late 2024 and mid-2025. The RCT intervention group will receive a fecundity knowledge intervention. The intervention consists of a short (3 minutes) animated educational video containing information on risk factors of importance for fecundity.
The primary outcome measure of the RCT is fecundity knowledge. The knowledge level is defined based on the following factors: Age; smoking; sexually transmitted infections; Success of spontaneous pregnancy according to female age; Success of pregnancy according to female age and fertility treatment. The secondary outcomes are: intentions regarding the timing of desired pregnancy/childbirth; fecundity-protective behaviors; life goals; future reproductive behavior- including attempts to conceive, termination of pregnancies and realized fertility The primary and secondary outcomes are measured with validated self-reported questionnaire items - except for certain items under reproductive behavior, such as 'realized fertility', which is measured through registries.
The target group is adult offspring of the two cohorts, the DNBC and MoBa. Outcomes of the trial will be analyzed for the total population participating in the RCT; for specific age-groups; for men and women; by socioeconomic status of the individuals and their families or origin; and for individuals with high and low risk preferences (measured through questionnaires).
Hypothesis: young adult women and men have low-moderate fecundity knowledge and an educational digital intervention will have an impact on the interventions' group fecundity knowledge and influence a) their family building intentions to desire a first and/or last child at a younger age, b) their fecundity-protective behaviors, c) their priority of life goals, d) their future reproductive behavior, including attempts to conceive, termination of pregnancies and realized fertility.
The goal is to enhance young adults' fecundity knowledge in order to secure that adults are able to make well-informed decisions regarding their family building and reproductive choices.
Individuals who are included in the RCT sample, will be randomized 1:1 by simple randomization to one of the following study arms:
I. Experimental arm (fecundity knowledge intervention group). In the experimental arm, Individuals receive a short (3 minutes) animated educational video on risk factors of importance for fecundity.
II. Control arm (no fecundity knowledge provided).
The investigators will use computer-based randomization methods. When analyzing the data, the data set will by necessity contain information on whether each individual is in the intervention or control group. Coding and classification of outcome variables will be done jointly for the intervention and control group, so this knowledge will not influence the investigators handling of the data.
The intervention group will be provided with information that should allow them to correctly answer questions on fecundity knowledge and fecundity risks factors. The fecundity information will be provided through a short animated educational video that will be sent out digitally. The control group is not receiving such information. As part of the overall BIOSFER project, all offspring in both birth cohorts have received a Global Questionnaire at baseline including items and scales measuring fecundity knowledge and the participants' family formation/intentions regarding family formation and views on life goals. Only participants' having responded to the Global Questionnaire will be invited to the RCT study. After the intervention, both the intervention and the control group will receive identical questionnaire items and scales on fecundity knowledge and intentions regarding family formation, and their views on life goals. Hence, all the respondents receive the questions that inform our outcome variables both before and after the intervention. The participants in the intervention and control group will also be asked about their fecundity-protective behavior.
Statistical analysis and interpretation of data:
Overall, 13,106 (23%) of MoBa participants have responded to the Global Questionnaire. In DNBC data collection of the Global Questionnaire will continue until April 2025. Currently, 11,900 (27% of those who has been invited so far) have responded to the Global Questionnaire. Participants responding to the Global Questionnaire in DNBC and MoBa will receive an invitation to the RCT study.
For the sample size calculation for the primary outcome the investigators expect a participation of 30%. This is based on previous response rates within similar data collections in the two cohorts. Power calculations for the primary outcome were performed with a 5% significance level. The investigators follow convention and use 80% power as a cutoff for sufficient power. Assuming a response rate of 30, there will be power to detect effects down to 5 percent (2.5pp) in the full sample, and 10 percent (5 pp) among women and men when analyzed separately.
The investigators also performed power calculations assessing how power varies as a function of sample size and effect size. The MoBa cohort is used as example, where the RCT invitation will be sent to all 13 106 respondents of the MoBa Global Questionnaire. The investigators also assess the power for sex-specific analysis, with 8325 women and 4723 men (58 answering "other" are excluded from these). The power calculation assumes an even split between groups, and then tests the power for difference in means.
In the power calculations, the investigators use a "fertility knowledge percentage correct score" (see e.g. Bunting et al 2013), with a range from 0 to 100%. The investigators assume a baseline of knowledge of 50 percentage points, somewhat less than what was found in Bunting et al. 2013 (65-68 points). The investigators expect the knowledge level to be lower in our population compared to the population in Bunting et al. 2013. The population in this study is younger (18-29) compared to Bunting et al.'s (31.8 years old). Further, 26% of Bunting et al.'s population already had children, which is expected to be lower in our population. Hence, younger age and not being a parent will most likely effect the knowledge level. With a standard deviation of 25 (taken from Bunting et al. 2013 p. 389), the investigators then assess the power to detect effects of 2.5, 5, 7.5 and 10 percentage points.
Across all samples and down to a 10% response rate, the investigators can detect effects of 7.5 percentage points or higher. In the combined sample, the investigators can detect effects as small as 5 percentage points at a 10% response rate. To detect the smallest effects (2.5 percentage points), a 30% response rate is required for the combined sample.
For women, the investigators can detect effects as small as 5 percentage points with a 10% response rate. To detect effects of 2.5 percentage points require a 40% response rate. In the male sample, effects of 7.5 percentage points and larger can be detected with a 10% response rate. Detecting a 5 pp effect requires 20% response, and 2.5 pp requires more than 50% response.
The effectiveness of the RCT will be analyzed using an intention-to-treat (ITT) approach.
The results of the quantitative evaluation (primary and secondary outcomes) is planned to be analyzed and published in more than one scientific paper.
The quantitative evaluation of RCT is complemented by a qualitative evaluation looking into the participants' thoughts on the fecundity knowledge intervention, highlighting what works for whom under which circumstances, but also their overall thought on family formation.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
PREVENTION
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Fecundity knowledge intervention
In the experimental arm, participants receive a short (3 minutes) educational video on risk factors of importance for fecundity.
Educational intervention
The educational intervention group will be provided with information that should allow them to correctly answer questions on fecundity knowledge and fecundity risks factors. The fecundity information will be provided through a short animated educational video (3 minutes) that will be sent out digitally. The control group is not receiving such information.
Control
In the no-intervention arm, the participants do not receive the intervention (a short educational video).
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Educational intervention
The educational intervention group will be provided with information that should allow them to correctly answer questions on fecundity knowledge and fecundity risks factors. The fecundity information will be provided through a short animated educational video (3 minutes) that will be sent out digitally. The control group is not receiving such information.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Being of legal age
* Responded to the Global Questionnaire at baseline
Exclusion Criteria
* Not understanding Norwegian/Danish language
18 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Danish National Birth Cohort (DNBC)
UNKNOWN
Norwegian Mother and Child Cohort Study (MoBa)
UNKNOWN
ERC Synergy Grant (European Union, 101071773)
UNKNOWN
University of Aarhus
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Mikko MyrskylÀ, Professor
Role: PRINCIPAL_INVESTIGATOR
Max Planck Institute for Demographic Research, Rostock, Germany
Cecilia Ramlau-Hansen, Professor
Role: PRINCIPAL_INVESTIGATOR
Department of Public Health - Department of Epidemiology, Aarhus University, Denmark
Siri Eldevik HÄberg, Professor
Role: PRINCIPAL_INVESTIGATOR
Centre for Fertility and Health, Norwegian Institute of Public Health, Norway
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Aarhus University/DNBC/SSI
Aarhus, , Denmark
Norwegian Institute of Public Health/MoBa
Oslo, , Norway
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
BIOSFER RCT - 101071773
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.